Transforming Oncology Treatment with Next-Generation Tumor Ablation Solutions in the US
The US tumor ablation market is on a trajectory of rapid expansion, poised to reach a valuation of $1.25 billion by 2035, reflecting a CAGR of 11.77%. This growth is primarily fueled by technological innovations that enhance the efficacy and safety of treatment options. The increasing prevalence of cancer in the United States has heightened the demand for effective, minimally invasive treatment...
0 Comments 0 Shares 124 Views 0 Reviews